Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › FP7

TROCAR · Translational Research on Combating Antimicrobial Resistance

FP7Status: CLOSED1 January 200930 June 2012EU funding €2,999,444

The health care systems of most European countries are based on a continuum from acute care hospitals, though other health care facilities to the community. Such a framework provides the perfect opportunity for the wide-spread dissemination of high-risk resistant clones or genetic resistant elements. The driving concept of TROCAR is to investigate the fundamentals of the epidemiology of new highly virulent multiresistant strains of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus spp., Extended-spectrum, metallo- and acquired AmpC beta-lactamase producing Enterobacteriaceae, multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii will focus on three major strategic aims: 1. The definition of the major high-risk resistant clones based on an appropriate representative collection and new clinical strains obtained during molecular epidemiological studies, in hospitals and laboratories collaborating with their respective National Excellence Laboratories in European countries using a standardised protocol. 2. The promotion of collaborative European research to investigate, by genomic and proteomic approaches, specific traits associated with virulence, transmission, persistence and resistance of epidemic clones in comparison with non-epidemic clones as well as resistance determinants and their genetic location in horizontal gene transfer units and their genetic environment. 3. The development of bioinformatics tools to fully exploit the genomics data and allow the rapid identification of resistant strains with heightened epidemic potential. By combining the outputs of the project it will be possible to provide tools for monitoring the spread of key community and nosocomial pathogens, to provide the scientific basis for an early warning system when isolates of a particular epidemicity appear in the community and nosocomial settings, to characterise specific genetic elements carrying resistance genes encoding, and to establish t

Consortium · 14 organisations

coordinator

CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER

ES · €593,501

participant

ETHNIKI SCHOLI DIMOSIAS YGEIAS

EL · €167,250

participant

UNIVERSITY OF BATH

UK · €175,500

participant

UNIVERSITA DEGLI STUDI DI SIENA

IT · €240,900

participant

SISTEMAS GENOMICOS SL

ES · €99,999

participant

ROBERT KOCH-INSTITUT

DE · €155,898

participant

EUROPEAN SOCIETY OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES E.V

DE · €66,000

participant

ACADEMISCH ZIEKENHUIS GRONINGEN

NL · €216,000

participant

HEALTH PROTECTION AGENCY HPA

UK · €213,426

participant

UNIVERSITE PARIS-SUD

FR · €198,000

participant

SERVICIO MADRILENO DE SALUD

ES · €234,000

participant

TERVEYDEN JA HYVINVOINNIN LAITOS

FI · €211,500

participant

UNIVERSITE DE CAEN NORMANDIE

FR · €235,458

participant

INSTITUTO DE TECNOLOGIA QUIMICA E BIOLOGICA - UNIVERSIDADE NOVA DE LISBOA

PT · €192,012

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.